+286.7%
GSK vs TRI
+552.2%
-265.5%
-49.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | TRI | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.3% | -3.8% | +1.5% | -1.2% |
| 7D | -3.0% | -3.9% | +0.9% | -1.9% |
| 30D | +0.4% | -4.4% | +4.8% | +1.3% |
| 3M | -1.2% | +5.8% | -7.0% | -3.6% |
| 6M | +0.9% | +27.7% | -26.8% | -8.3% |
| YTD | +4.0% | -18.0% | +22.0% | +6.3% |
| 1Y | +7.3% | -20.8% | +28.1% | +11.0% |
| 3Y | +57.1% | -19.1% | +76.2% | +58.7% |
| 5Y | +43.0% | -4.9% | +47.8% | +34.7% |
| 10Y | +103.1% | +204.5% | -101.5% | +24.5% |
| All | +286.7% | +552.2% | -265.5% | +62.1% |
Cumulative growth
Daily Returns
Daily percentage return beside TRI.
Daily Out/Under-Performance
Portfolio return minus TRI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TRI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded TRI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling